Berlin, Germany

Jean-Claude Hilscher

This inventor holds 5 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1976-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude Hilscher. Retrieved from https://idiyas.com/inventor/jean-claude-hilscher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1976-1998

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Claude Hilscher

Introduction

Jean-Claude Hilscher is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on the development of complex chemical compounds that have important applications in medicine.

Latest Patents

Hilscher's latest patents include innovative advancements such as Derivatized DTPA complexes and pharmaceutical agents containing these complexes. Additionally, he has developed a process for the production of C-substituted diethylenetriamines, which showcases his expertise in chemical synthesis and pharmaceutical development.

Career Highlights

Jean-Claude Hilscher is currently employed at Schering Aktiengesellschaft, a prominent pharmaceutical company. His role at Schering has allowed him to work on cutting-edge research and development projects that aim to improve healthcare outcomes.

Collaborations

Throughout his career, Hilscher has collaborated with esteemed colleagues, including Heribert Schmitt-Willich and Johannes Platzek. These partnerships have fostered a collaborative environment that enhances innovation and drives successful research initiatives.

Conclusion

Jean-Claude Hilscher's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of important medical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…